File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Inflammation in Alzheimer's Disease and Molecular Genetics: Recent Update

TitleInflammation in Alzheimer's Disease and Molecular Genetics: Recent Update
Authors
Issue Date2015
Citation
Archivum Immunologiae et Therapiae Experimentalis, 2015 How to Cite?
AbstractAlzheimer's disease (AD) is a complex age-related neurodegenerative disorder of the central nervous system. Since the first description of AD in 1907, many hypotheses have been established to explain its causes. The inflammation theory is one of them. Pathological and biochemical studies of brains from AD individuals have provided solid evidence of the activation of inflammatory pathways. Furthermore, people with long-term medication of anti-inflammatory drugs have shown a reduced risk to develop the disease. After three decades of genetic study in AD, dozens of loci harboring genetic variants influencing inflammatory pathways in AD patients has been identified through genome-wide association studies (GWAS). The most well-known GWAS risk factor that is responsible for immune response and inflammation in AD development should be APOE ε4 allele. However, a growing number of other GWAS risk AD candidate genes in inflammation have recently been discovered. In the present study, we try to review the inflammation in AD and immunity-associated GWAS risk genes like HLA-DRB5/DRB1, INPP5D, MEF2C, CR1, CLU and TREM2.
Persistent Identifierhttp://hdl.handle.net/10722/214978

 

DC FieldValueLanguage
dc.contributor.authorZhang, Z-
dc.contributor.authorLi, Y-
dc.contributor.authorNg, CT-
dc.contributor.authorSong, Y-
dc.date.accessioned2015-08-21T12:16:08Z-
dc.date.available2015-08-21T12:16:08Z-
dc.date.issued2015-
dc.identifier.citationArchivum Immunologiae et Therapiae Experimentalis, 2015-
dc.identifier.urihttp://hdl.handle.net/10722/214978-
dc.description.abstractAlzheimer's disease (AD) is a complex age-related neurodegenerative disorder of the central nervous system. Since the first description of AD in 1907, many hypotheses have been established to explain its causes. The inflammation theory is one of them. Pathological and biochemical studies of brains from AD individuals have provided solid evidence of the activation of inflammatory pathways. Furthermore, people with long-term medication of anti-inflammatory drugs have shown a reduced risk to develop the disease. After three decades of genetic study in AD, dozens of loci harboring genetic variants influencing inflammatory pathways in AD patients has been identified through genome-wide association studies (GWAS). The most well-known GWAS risk factor that is responsible for immune response and inflammation in AD development should be APOE ε4 allele. However, a growing number of other GWAS risk AD candidate genes in inflammation have recently been discovered. In the present study, we try to review the inflammation in AD and immunity-associated GWAS risk genes like HLA-DRB5/DRB1, INPP5D, MEF2C, CR1, CLU and TREM2.-
dc.languageeng-
dc.relation.ispartofArchivum Immunologiae et Therapiae Experimentalis-
dc.titleInflammation in Alzheimer's Disease and Molecular Genetics: Recent Update-
dc.typeArticle-
dc.identifier.emailZhang, Z: zzg16@hku.hk-
dc.identifier.emailSong, Y: songy@hku.hk-
dc.identifier.authoritySong, Y=rp00488-
dc.identifier.doi10.1007/s00005-015-0351-0-
dc.identifier.hkuros249717-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats